Evaluation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in human cases with orofacial clefts: A systematic review

被引:0
|
作者
Imani, Mohammad Moslem [1 ]
Shalchi, Majid [2 ]
Ahmadabadi, Gholamhassan [3 ]
Sadeghi, Masoud [4 ]
机构
[1] Kermanshah Univ Med Sci, Dept Orthodont, Kermanshah, Iran
[2] Guilan Univ Med Sci, Sch Dent, Dept Orthodont, Rasht, Iran
[3] Kermanshah Univ Med Sci, Students Res Comm, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran
关键词
Oral clefts; Matrix metalloproteinase; Tissue inhibitors of; metalloproteinase; Apoptosis; Interaction; Systematic review; LIP AND/OR PALATE; ASSOCIATION; POLYMORPHISM; LIP/PALATE; EXPRESSION; GENES; METAANALYSIS; FIBROBLASTS; APOPTOSIS; PATHWAYS;
D O I
10.1016/j.ortho.2023.100781
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction > The interaction between several cell populations or many genes and the coordina-tion of multiple signal transmission pathways can lead to defects such as orofacial clefts (OFCs). Herein, a systematic review was designed to evaluate a group of important biomarkers (matrix metalloproteinases [MMPs] and tissue inhibitors of metalloproteinases [TIMPs]) in human cases with OFCs.Material and methods > Four databases including PubMed, Scopus, Web of Science, and Cochrane Library databases were searched until March 10, 2023, without any restriction. STRING, the protein-protein interaction (PPI) network software, was applied to investigate the functional interactions among the examined genes. The effect sizes including odds ratio (OR) dealing with a 95% confidence interval (CI), were extracted by the Comprehensive Meta-Analysis version 2.0 (CMA 2.0) software.Results > Thirty-one articles were entered into the systematic review that four articles were analyzed in the meta-analysis. Single studies reported that several polymorphisms of MMPs (rs243865, rs9923304, rs17576, rs6094237, rs7119194, and rs7188573); and TIMPs (rs8179096, rs7502916, rs4789936, rs6501266, rs7211674, rs7212662, and rs242082) had an association with OFC risk. There was no significant difference for MMP-3 rs3025058 polymorphism in allelic (OR: 0.832; P = 0.490), dominant (OR: 1.177; P = 0.873), and recessive (OR: 0.363; P = 0.433) models and MMP-9 rs17576 polymorphism in an allelic model (OR: 0.885; P = 0.107) between the OFC cases and the controls. Based on immunohistochemistry reports, three MMPs (MMP-2, MMP-8, and MMP-9) and TIMP-2 had significant correlations with several other biomarkers in OFC cases.Conclusions > MMPs and TIMPs can impact the tissue and cells affected by OFCs and the process of apoptosis. The interaction between some biomarkers with MMPs and TIMPs (e.g., TGFb1) in OFCs can be interesting for future research.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Imbalance of expression of matrix metalloproteinases (MMPS) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
    Bramhall, SR
    Neoptolemos, JP
    Stamp, GWH
    Lemoine, NR
    JOURNAL OF PATHOLOGY, 1997, 182 (03): : 347 - 355
  • [2] Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human Gingiva
    Ejeil, AL
    Igondjo-Tchen, S
    Ghornrasseni, S
    Pellat, B
    Godeau, G
    Gogly, B
    JOURNAL OF PERIODONTOLOGY, 2003, 74 (02) : 188 - 195
  • [3] Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas
    Kumamoto, H
    Yamauchi, K
    Yoshida, M
    Ooya, K
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (02) : 114 - 120
  • [4] Expression of matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPS) by human intestinal myofibroblasts (IMFS)
    Mckaig, B
    Collins, H
    Hawkey, C
    Watson, S
    Mahida, Y
    GUT, 2000, 46 : A38 - A38
  • [5] Expression of matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPS) by human intestinal myofibroblasts.
    McKaig, BC
    Collins, H
    Hawkey, CJ
    Watson, S
    Mahida, YR
    GASTROENTEROLOGY, 2000, 118 (04) : A551 - A551
  • [6] Matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPS) in bovine luteal cell cultures.
    Tsang, PCW
    Poff, JP
    Fernandez, CA
    Moses, MA
    BIOLOGY OF REPRODUCTION, 1997, 56 : 455 - 455
  • [7] ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
    Glazewska, Edyta K.
    Niczyporuk, Marek
    Lawicki, Slawomir
    Szmitkowski, Maciej
    Zajkowska, Monika
    Donejko, Magdalena
    Przylipiak, Andrzej
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2018, 35 (02): : 167 - 173
  • [8] Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in bronchial squamous preneoplastic lesions (BSPL).
    Galateau-Salle, F
    Luna, RE
    Horiba, K
    Sheppard, MN
    Hayashi, T
    Fleming, MV
    Colby, TV
    Bennett, W
    Harris, CC
    Stetler-Stevenson, WG
    Liotta, LA
    Ferrans, VJ
    Travis, WD
    MODERN PATHOLOGY, 1998, 11 (01) : 174A - 174A
  • [9] Vascular remodeling factors in Kawasaki disease - Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs)
    Sakata, K
    Onouchi, Z
    Hamaoka, K
    Yamamoto, Y
    PEDIATRIC RESEARCH, 2000, 47 (04) : 553 - 553
  • [10] The activity of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats
    Kawai, K
    Uetsuka, K
    Doi, K
    Nakayama, H
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2006, 68 (02): : 105 - 111